What Sanofi Early Research Chief Scientist Frank Nestle Is Most Excited About
Immunology And Oncology Pipelines Expanding
Sanofi's Nestle talked to Scrip about the company's early pipeline, the emerging technologies he thinks are most promising and tapping external innovation.
